Novodiag® RESP-4 Assay
Fully-automated on-demand testing that enables differentiated detection of SARS-CoV-2, Flu A, Flu B and RSV.
CE marked. Not for sale in the US.
Novodiag® RESP-4 Assay
Fully-automated on-demand testing that enables differentiated detection of SARS-CoV-2, Flu A, Flu B and RSV.
Overview
Documents
Assay Highlights
The Novodiag RESP-4 assay, performed with the Novodiag System, is a cartridge-based molecular test for the detection and differentiation of SARS-CoV-2, Flu A, Flu B and RSV in one single assay. The test uses nasopharyngeal swab samples from patients.
CE marked. Not for sale in the US.
Smart Simplicity in On-demand Testing
Cartridge-based, on-demand testing, that delivers clinical confidence in approximately an hour.
Features & Benefits
The Novodiag® Solution allows a simple and fast way to pinpoint patients most at risk with targeted, multiplex and syndromic on-demand testing.
- Accurate diagnosis during respiratory viral season.
- Guiding appropriate treatment of patients.
- Reliable results.
- Prevention of false negative results due to inadequate sampling.
- Good reproducibility, precision and productivity.
- Ensures users safety, protects from possible contamination.
- Fast diagnosis and infection control implementation.
- Time and cost effectiveness.
- Improved patient outcome
- Improved workflow and time to results.
- Increased lab revenue.
- Time and labour saving.
- No need for highly trained personnel enabling decentralised testing.
Documents
The Novodiag RESP-4 assay enables fast on-demand diagnosis of SARS-CoV-2, Flu A, Flu B and RSV.
